ORM-10103
ORM-10103 is a specific inhibitor of the Na+/Ca2+ exchanger (NCX), which decreases the NCX current with estimated IC50s of 55 and 67 nM at -80 and at 20 mV, respectively[1][2].
Product Specifications
CAS Number
488847-28-5
UNSPSC
12352005
Hazard Statement
H301, H413
Target
Na+/Ca2+ Exchanger
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/orm-10103.html
Concentration
10mM
Purity
99.43
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=[N+](C1=CN=C(OC2=CC=C3C(CCC(C4=CC=CC=C4)O3)=C2)C=C1)[O-]
Molecular Formula
C20H16N2O4
Molecular Weight
348.35
Precautions
H301, H413
References & Citations
[1]Jost N, et al. ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart. Br J Pharmacol. 2013 Oct;170 (4) :768-78.|[2]Kohajda Z, et al. The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments. PLoS One. 2016 Nov 10;11 (11) :e0166041.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
033371-ML405 100 µL
Ccna1, ID (Ccna1, Cyclin-A1) (MaxLight 405) discontinued
Sign In for Pricing
View Details MBS6295985-01 0.2 mL
EphA2, Phosphorylated (S897) (EPHA2, ECK, Ephrin type-A receptor 2, Epithelial cell kinase, Tyrosine-protein kinase receptor ECK) (AP)
Sign In for Pricing
View Details MBS6295985-02 5x 0.2 mL
EphA2, Phosphorylated (S897) (EPHA2, ECK, Ephrin type-A receptor 2, Epithelial cell kinase, Tyrosine-protein kinase receptor ECK) (AP)
Sign In for Pricing
View Details 
MBS2149401-01 0.1 mL
PE-Linked Monoclonal Antibody to Inulin Receptor (INSR)
Sign In for Pricing
View Details